A Billing Agent Is Not Automatically the Treating Provider

Healthcare practices routinely authorize another company to prepare claims, verify eligibility, collect payments and appeal denials. These arrangements can be entirely legitimate. But an agreement to perform administrative work is not the same question as who actually delivered clinical care.

An investigator evaluating delegated claims should separate at least four roles: the professional who performed the service, the practice or organization contracted with the patient and plan, the billing organization submitting the claim, and the entity authorized to receive funds. These roles can overlap, but they should not simply be assumed to be interchangeable.

One critical distinction is between an agent acting on behalf of a licensed provider and an organization asserting its own clinical-group participation. An administrative agent might have permission to transmit a claim and receive assigned payments without itself employing the treating professional or operating the clinical practice. The exact contract language, payer enrollment records, assignments and claim fields matter.

An explanation of benefits that displays an organization name is not enough to establish an inaccurate rendering provider. The full electronic 837P or paper CMS-1500, together with the relevant payer agreement, is needed to distinguish the billing provider, rendering provider and pay-to relationships.

Questions worth documenting include: Which legal entity contracted with the clinician? Does the agreement allow delegation to a different company? How was the individual clinician enrolled or affiliated with the billed group? Which entity owns the receivable? What does the payer see in the original claim? Can the treating clinician audit the final submitted representation?

The goal of these questions is accurate, reviewable billing—not an assumption that every intermediary arrangement is unlawful. When a company describes itself both as a management services organization and as a clinical group, regulators should be able to examine the underlying records rather than relying on labels alone.

Sunshyn's position is straightforward: patients, clinicians and insurers all benefit when clinical responsibility and claim identity can be traced to actual contractual authority. An agreement to help with billing should never eliminate the need for that traceability.